Explore PMOS Research
Search 20,710 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies6,081–6,100 of 20,710
All studies
The reference value of anti-Müllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study
Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome
Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks
Trends in metabolic dysfunction in polycystic ovary syndrome: a bibliometric analysis
Depletion of gut microbiota influents glucose metabolism and hyperandrogenism traits of mice with PCOS induced by letrozole
Eight-Hour Time-Restricted Feeding: A Strong Candidate Diet Protocol for First-Line Therapy in Polycystic Ovary Syndrome
Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?
Current Advances in Cellular Approaches for Pathophysiology and Treatment of Polycystic Ovary Syndrome
Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes
Changes in circulating forms of anti-Muüllerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy
The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner’s Results
Effects of n-3 PUFA supplementation on oocyte in vitro maturation in mice with polycystic ovary syndrome
Specific Alteration of Branched-Chain Amino Acid Profile in Polycystic Ovary Syndrome
Metabolic Deregulations in Patients with Polycystic Ovary Syndrome
Effects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis
Circulating bile acid profile characteristics in PCOS patients and the role of bile acids in predicting the pathogenesis of PCOS
Characteristics and possible mechanisms of metabolic disorder in overweight women with polycystic ovary syndrome
Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects
Trait emotional intelligence and quality of life in women with polycystic ovary syndrome: Dysmorphic concerns and general distress as mediators